VerifiedBiotechnology Research

Pulmovant

Pulmovant is a clinical-stage biotechnology company developing innovative therapies for patients suffering from pulmonary diseases. Pulmovant’s first program, mosliciguat is designed to provide an effective, once-daily, inhaled treatment option for patients with pulmonary hypertension (PH). Mosliciguat is a novel, potential first-in-class, sGC activator with a differentiated mechanism that may have broad applicability across the PH spectrum.

7-day free trial · no credit card

Waltham, United States47(11 to 50)pulmovant.com LinkedIn

Verified contacts

32

available on Kipplo

LinkedIn employees

47

11 to 50 range

Open roles

—

no listings

Distinct roles

11

indexed titles

Tech stack

1

tools in use

Monthly traffic

—

organic / mo

Sign up free to see all 32 verified contacts at Pulmovant

Free for 7 days · 50 credits · no card · only pay for verified records.

Decision-makers and verified team members

32 contacts with verified email or phone · masked until revealed.

Sign up free →

Showing 9 of 32 verified contacts

Top roles at Pulmovant

11 distinct titles indexed · top 10 shown.

2roivant
2senior medical director
1()
1, -
1assoc director, field based medicine
1executive assistant
1senior director, clinical operations
1sr clinical trial manager
1sr director, field medical
1svp, head of finance
+1more titles

Sign up to unlock all 32 contacts at Pulmovant

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up to reveal 32 verified contacts at Pulmovant

7-day trial · no credit card · cancel anytime · only pay for verified records.

Sign up free See pricing

Trusted by sales, marketing, and GTM engineering teams.

Pulmovant | Kipplo Discover